Elacestrant Benefit in Breast Cancer, but Compared to What?
The novel drug showed benefit in a phase 3 trial in advanced/metastatic breast cancer, but there was no combination therapy in the control arm.
Source: medscape.com
Stay updated with breaking news from Over Standard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The novel drug showed benefit in a phase 3 trial in advanced/metastatic breast cancer, but there was no combination therapy in the control arm.